M&A Deal Summary

Myonexus Therapeutics Acquires SaveWay

On April 10, 2024, Myonexus Therapeutics acquired life science company SaveWay

Acquisition Highlights
  • This is Myonexus Therapeutics’ 1st transaction in the Life Science sector.
  • This is Myonexus Therapeutics’ 1st transaction in the United States.
  • This is Myonexus Therapeutics’ 1st transaction in Delaware.

M&A Deal Summary

Date 2024-04-10
Target SaveWay
Sector Life Science
Buyer(s) Myonexus Therapeutics
Deal Type Add-on Acquisition

Target

SaveWay

Newark, Delaware, United States
SaveWay is a local community resource for affordable, non-sterile compounded medications. The Company offers custom sterile and non-sterile compounded medications that can be personalized based on dose or delivery system. SaveWay was founded in 2001 and is based in Newark, Delaware.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Myonexus Therapeutics

New Albany, Ohio, United States

Category Company
Founded 2017
Sector Life Science
DESCRIPTION

Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for limb girdle muscular dystrophies (LGMDs) based on research at Nationwide Children’s Hospital, a provider in neuromuscular gene therapy discovery and translational research. Myonexus Therapeutics was founded in 2017 and is based in New Albany, Ohio.


DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Delaware) 1 of 1
Country (United States) 1 of 1
Year (2024) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-03-15 Creapharm’s Clinical & Commercial Packaging and Bioservices Business

Reims, France

Creapharm’s Clinical & Commercial Packaging and Bioservices Business provides clinical packaging and distribution to commercial packaging and advanced therapy medicinal products (ATMPs) supply chain management.

Buy -